MedTrace Logo

Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye

NCT01959854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-10-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of an ophthalmic solution containing 0.2% xanthan gum in reducing symptoms and signs of dry eye as well as tear film markers of oxidative stress.

Conditions

  • Dry Eye

Interventions

DEVICE

carboxymethylcellulose

0.25% carboxymethylcellulose preservative free

DEVICE

xanthan gum

0.2% xanthan gum preservative free

Sponsors & Collaborators

  • SIFI SpA

    lead INDUSTRY

Principal Investigators

  • Pasquale Aragona, MD · University of Messina (ITALY)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01959854 on ClinicalTrials.gov